Cargando…
FMK, an Inhibitor of p90RSK, Inhibits High Glucose-Induced TXNIP Expression via Regulation of ChREBP in Pancreatic β Cells
Hyperglycemia is the major characteristic of diabetes mellitus, and a chronically high glucose (HG) level causes β-cell glucolipotoxicity, which is characterized by lipid accumulation, impaired β-cell function, and apoptosis. TXNIP (Thioredoxin-interacting protein) is a key mediator of diabetic β-ce...
Autores principales: | Han, Jung-Hwa, Kim, Suji, Kim, Sujin, Lee, Heejung, Park, So-Young, Woo, Chang-Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770409/ https://www.ncbi.nlm.nih.gov/pubmed/31505737 http://dx.doi.org/10.3390/ijms20184424 |
Ejemplares similares
-
Dual regulation of TxNIP by ChREBP and FoxO1 in liver
por: Noblet, Benedicte, et al.
Publicado: (2021) -
ChREBP Mediates Glucose-Stimulated Pancreatic β-Cell Proliferation
por: Metukuri, Mallikarjuna R., et al.
Publicado: (2012) -
Integrated Expression Profiling and Genome-Wide Analysis of ChREBP Targets Reveals the Dual Role for ChREBP in Glucose-Regulated Gene Expression
por: Jeong, Yun-Seung, et al.
Publicado: (2011) -
Adaptive and maladaptive roles for ChREBP in the liver and pancreatic islets
por: Katz, Liora S., et al.
Publicado: (2021) -
Islet ChREBP-β is increased in diabetes and controls ChREBP-α and glucose-induced gene expression via a negative feedback loop
por: Jing, Gu, et al.
Publicado: (2016)